A common cholesterol drug could help weaken a fluid shield that helps ovarian cancer tumours survive, early lab findings suggest. The findings do not show the...
Artera has won FDA clearance for ArteraAI Breast, its breast cancer platform for patients with early-stage HR-positive, HER2-negative invasive breast cancer. ArteraAI Breast is the first...
A nurse who works with breast cancer patients has spoken of her pride after joining a trial that improved breast cancer surgery after her own diagnosis....
Obesity may be a key driver of rising rates of 11 cancers in adults under 50, a study has found. The 11 cancers were thyroid, multiple...
Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests. Researchers said excess weight is...
An AI tool could help spot breast cancer risk by analysing how individual breast cells behave when squeezed under stress, research suggests. Researchers at City of...
An experimental drug slowed triple-negative breast cancer in mice by flooding tumour cells with toxic fats. Triple-negative breast cancer lacks three common drug targets, making it...
